A detailed history of Financial Engines Advisors L.L.C. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Engines Advisors L.L.C. holds 78,094 shares of ABBV stock, worth $14.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
78,094
Previous 80,610 3.12%
Holding current value
$14.1 Million
Previous $13.8 Million 11.54%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $412,221 - $501,514
-2,516 Reduced 3.12%
78,094 $15.4 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $672,562 - $785,402
4,345 Added 5.7%
80,610 $13.8 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $1.4 Million - $1.59 Million
-8,729 Reduced 10.27%
76,265 $13.9 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $77,468 - $87,248
563 Added 0.67%
84,994 $13.2 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $894,518 - $1.04 Million
-6,696 Reduced 7.35%
84,431 $12.6 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $631,675 - $786,078
-4,767 Reduced 4.97%
91,127 $12.3 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $367,598 - $423,344
-2,542 Reduced 2.58%
95,894 $15.3 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.69 Million - $2.02 Million
12,184 Added 14.13%
98,436 $15.9 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $1.84 Million - $2.11 Million
-13,687 Reduced 13.7%
86,252 $11.6 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $768,882 - $977,501
-5,587 Reduced 5.29%
99,939 $15.3 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $633,899 - $786,491
-4,803 Reduced 4.35%
105,526 $17.1 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $671,544 - $849,698
6,251 Added 6.01%
110,329 $14.9 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $727,031 - $825,289
-6,833 Reduced 6.16%
104,078 $11.2 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $1.73 Million - $1.92 Million
-16,404 Reduced 12.88%
110,911 $12.5 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $354,060 - $389,777
-3,461 Reduced 2.65%
127,315 $13.8 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $1.53 Million - $2.07 Million
19,057 Added 17.06%
130,776 $14 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $765,028 - $897,891
-8,905 Reduced 7.38%
111,719 $9.79 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $1.01 Million - $1.34 Million
-13,699 Reduced 10.2%
120,624 $11.8 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $899,065 - $1.36 Million
-13,939 Reduced 9.4%
134,323 $10.2 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $611,734 - $765,410
8,481 Added 6.07%
148,262 $13.1 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $1.62 Million - $1.95 Million
25,741 Added 22.57%
139,781 $10.6 Million
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $990,164 - $1.27 Million
-15,071 Reduced 11.67%
114,040 $8.29 Million
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $1.09 Million - $1.28 Million
14,143 Added 12.3%
129,111 $10.4 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $963,004 - $1.19 Million
-12,370 Reduced 9.71%
114,968 $10.6 Million
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $1.13 Million - $1.26 Million
-12,748 Reduced 9.1%
127,338 $11.9 Million
Q2 2018

Jul 27, 2018

SELL
$89.78 - $106.23 $1.33 Million - $1.58 Million
-14,850 Reduced 9.58%
140,086 $13 Million
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $1.85 Million - $2.48 Million
-20,101 Reduced 11.48%
154,936 $14.7 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $4.46 Million - $4.89 Million
-49,775 Reduced 22.14%
175,037 $16.9 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $15.7 Million - $20.1 Million
224,812
224,812 $20 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Engines Advisors L.L.C. Portfolio

Follow Financial Engines Advisors L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.